Deliveristo is the Italian food delivery platform dedicated to B2B.

Deliveristo offers an innovative service: it digitizes the current supplies of restaurateurs and chefs thanks to a platform that puts them in direct contact with producers in an easy, fast and efficient way, eliminating all intermediaries.

Deliveristo was founded in 2017 by Ivan Aimo and Luca Calia, two thirty-year-olds with a training halfway between physical engineering and business administration, who coordinate a group of young entrepreneurs and stratuppers who deal with the selection of producers, consultancy to restaurateurs, customer care that monitors the efficiency and punctuality of deliveries.

Just one year after the commercial launch, 300 producers have already joined (of which about thirty produce dairy products), for a total of about 8000 products and 300 chefs/restaurants who have purchased, generating a turnover with an average constant growth of 40% month on month from launch to date.

ACBC is an innovative start-up that designs and manufactures patented sustainable footwear. Founded in 2017 by two young Italians, Edoardo Iannuzzi and Gio Giacobbe, ACBC has immediately becaome global thanks to a video that has reached 50 million views and over 2,500 worldwide customers.   So far ACBC holds 13 single brand stores in 9 countries and has co-branded partnerships with brands including Moschino and Armani.

Acbc has created a revolutionary concept of footwear, which allows the interchangeability of all models of soles and all models of uppers through a zipper. The technology is protected by a patent extended to all major world markets.

In addition to customising shoes, ACBC offers a perfect product for travelling without packaging space for footwear and offers clear advantages from eco-sustainability point of view. Indeed, by sharing the same sole for multiple shoes, there are obvious and significant savings in terms of emissions at the production stage.

The AorticLab system is part of the treatment of the pathology of the Aortic Valve caused by its degeneration by calcification of the valve flaps and is composed of two devices: the TAF-Filter anti-embolic and the TDD-Decalcification System (debridement). 

The treatment of this pathology is still carried out through the traditional surgical method SAVR (Surgical Aortic Valve Replacement), although there is a fast and progressive replacement with a much less invasive procedure such as TAVI/TAVR (Transcatheter Aortic Valve Implantation/ Replacement) technique that, in addition to avoiding open surgery, is applicable on a wider base of patients.

• TAF-Transcatether Antiembolic Filter: it is a new generation technology. Based on very recent studies on patients with severe aortic stenosis treated with TAVI the use of anti-embolic filters (TAF) is increasingly recommended as their use leads to a reduction in the frequency of ischemic events and brain injuries.
• TDD-Transcatheter Debridement Device: is a potentially disruptive technology. It consists of a revolutionary conservative treatment that fits into a fast-growing context such as TAVI and complements and supports its applicability.

Rejoint ha sviluppato una soluzione specifica per ogni paziente nell'ambito del trattamento dell’artroplastica totale del ginocchio: Yourknee, unico sistema al mondo basato sull'integrazione di tecnologie 3D Additive Manufacturing (AM), Artificial Intelligence (AI), Computer Aided Surgery (C.A.S.) e Internet of Things (IoT). 

La campagna si è conclusa con successo.